Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

The perverse one is where the new patented version is only marginally more effective but 5x the price and they stop making the old one.

It's a sick system.



Is the new, still under patent, insulin that much better than what would be available to a generic manufacturer? If the previous generation would work for plenty of patients that’s a huge market opportunity.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: